U.S. Markets closed

Medigus Ltd. (MDGS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9400-0.1700 (-5.47%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.1100
Open3.0600
Bid2.9300 x 1000
Ask2.9800 x 2200
Day's Range2.8800 - 3.0900
52 Week Range0.8300 - 5.1500
Volume642,766
Avg. Volume5,783,293
Market Cap23.56M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Why Medigus Stock Is Trading Higher Today

    Medigus (NASDAQ: MDGS) shares are trading higher on Tuesday after the company announced it was informed by Smart Repair Pro that all of Amazon's required regulatory processes were completed, which allows for the opening of its store in the UK, France, Italy, Germany and Spain.Medigus is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease).Medigus shares traded up 57.78% to $2.98 on Tuesday at the time of publication. The stock has a 52-week high of $5.15 and a 52-week low of 83 cents.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Why Medigus Stock Is Trading Higher Today * Why Medigus's Stock Is Trading Higher Today(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Why Medigus's Stock Is Trading Higher Today
    Benzinga

    Why Medigus's Stock Is Trading Higher Today

    Medigus Ltd (NASDAQ: MDGS) shares are trading higher on Friday after the company announced it will acquire a controlling interest in Smart Repair Pro and Purex Inc.Medigus is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how.The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products, including the micro ScoutCam 1.2 for both medical and industrial applications. Medigus earns the majority of its revenue from the USA.Medigus's stock traded up 10.96% at $1.52 per share at the time of publication on Friday. The stock has a 52-week high of $5.15 and a 52-week low of 83 cents.See more from Benzinga * Why Trevena's Stock Is Trading Higher Today * Why Gevo's Stock Is Trading Higher Today * Mayer's Departure From TikTok 'A Huge Blow': Wedbush Analyst(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • GlobeNewswire

    GERD IP, A Subsidiary of Medigus, Files Complaint with Delaware District Court Alleging Infringement of two Proprietary Patents

    OMER, Israel, July 13, 2020 -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization.